SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

RBC Capital Initiates Coverage On Homology Medicines with Outperform Rating, Announces Price Target of $30

RBC Capital initiates coverage on Homology Medicines (NASDAQ:FIXX) with a Outperform rating and announces Price Target of $30.

Benzinga · 05/13/2020 09:00

RBC Capital initiates coverage on Homology Medicines (NASDAQ:FIXX) with a Outperform rating and announces Price Target of $30.